Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Janssen, Stefan ^a   Glanzmann, Christoph ^a   Huber, Gerhard ^a   Studer, Gabriela ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Carotid sparing; Glottic cancer; IMRT; Partial larynx sparing

Indexed keywords

CETUXIMAB; CISPLATIN; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CAROTID ARTERY; COHORT ANALYSIS; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNGECTOMY; LARYNX; LARYNX CANCER; LARYNX EDEMA; LASER SURGERY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODAL IMAGING; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; STOMACH TUBE; SYSTEMIC THERAPY; UNSPECIFIED SIDE EFFECT; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONSERVATIVE TREATMENT; DRUG EFFECTS; GLOTTIS; LARYNGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; RISK FACTOR; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CAROTID ARTERIES; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84902053689     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-136     Document Type: Article

References (35)

1. Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Management of T1-T2 glottic carcinomas. Cancer 2004, 100:1786-1792.
2. Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 2006, 64:77-82.
3. Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, Bentzen J, Bastholt L, Hansen O, Johansen J, Andersen L, Evensen JF. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003, 362:933-940.
4. Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, Thorstad W, Wagner H, Ensley JF, Cooper JS. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013, 31:845-852.
5. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349:2091-2098.
6. Silverberg GD, Britt RH, Goffinet DR. Radiation-induced carotid artery disease. Cancer 1978, 41:130-137.
7. Bilora F, Pietrogrande F, Petrobelli F, Polato G, Pomerri F, Muzzio PC. Is radiation a risk factor for atherosclerosis? An echo-color Doppler study on Hodgkin and non-Hodgkin patients. Tumori 2006, 92:295-298.
8. Greco A, Gallo A, De Virgilio A, Marinelli C, Macri GF, Fusconi M, Pagliuca G, de Vincentiis M. Carotid stenosis after adjuvant cervical radiotherapy in patients with head and neck cancers: a prospective controlled study. Clin Otolaryngol 2012, 37:376-381.
9. Dorth JA, Patel PR, Broadwater G, Brizel DM. Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy. Head Neck 2014, 36(2):215-219.
10. Martin JD, Buckley AR, Graeb D, Walman B, Salvian A, Hay JH. Carotid artery stenosis in asymptomatic patients who have received unilateral head-and-neck irradiation. Int J Radiat Oncol Biol Phys 2005, 63:1197-1205.
11. Cheng SW, Ting AC, Ho P, Wu LL. Accelerated progression of carotid stenosis in patients with previous external neck irradiation. J Vasc Surg 2004, 39:409-415.
12. Plummer C, Henderson RD, O'Sullivan JD, Read SJ. Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review. Stroke 2011, 42:2410-2418.
13. Smith GL, Smith BD, Buchholz TA, Giordano SH, Garden AS, Woodward WA, Krumholz HM, Weber RS, Ang KK, Rosenthal DI. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol 2008, 26:5119-5125.
14. Haynes JC, Machtay M, Weber RS, Weinstein GS, Chalian AA, Rosenthal DI. Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation. Laryngoscope 2002, 112:1883-1887.
15. Chera BS, Amdur RJ, Morris CG, Mendenhall WM. Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord. Int J Radiat Oncol Biol Phys 2010, 77:1380-1385.
16. Sert F, Karakoyun-Celik O, Esassolak MA. Can carotid-sparing radiotherapy approaches replace with conventional techniques for the patients with T1 glottic larynx cancer?. Kulak Burun Bogaz Ihtis Derg 2012, 22:267-274.
17. Atalar B, Gungor G, Caglar H, Aydin G, Yapici B, Ozyar E. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer. Tumori 2012, 98:331-336.
18. Riegel AC, Antone J, Schwartz DL. Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer. Med Dosim 2013, 38:66-69.
19. Mourad WF, Hu KS, Shourbaji RA, Dolan J, Blakaj DM, Shasha D, Harrison LB. Exploration of the role of radiotherapy in the management of early glottic cancer with complete carotid artery occlusion. Onkologie 2013, 36:433-435.
20. Rosenthal DI, Fuller CD, Barker JL, Mason B, Garcia JA, Lewin JS, Holsinger FC, Stasney CR, Frank SJ, Schwartz DL, Morrison WH, Garden AS, Ang KK. Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer. Int J Radiat Oncol Biol Phys 2010, 77:455-461.
21. Osman SO, Astreinidou E, de Boer HC, Keskin-Cambay F, Breedveld S, Voet P, Al-Mamgani A, Heijmen BJ, Levendag PC. IMRT for image-guided single vocal cord irradiation. Int J Radiat Oncol Biol Phys 2012, 82:989-997.
22. Osman SO, de Boer HC, Astreinidou E, Gangsaas A, Heijmen BJ, Levendag PC. On-line cone beam CT image guidance for vocal cord tumor targeting. Radiother Oncol 2009, 93:8-13.
23. Eisbruch A, Foote RL, O'Sullivan B, Beitler JJ, Vikram B. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 2002, 12:238-249.
24. Pantel M, Wittekindt C, Altendorf-Hofmann A, Boeger D, Buentzel J, Esser D, Mueller A, Wendt TG, Guntinas-Lichius O. Diversity of treatment of T2N0 glottic cancer of the larynx: lessons to learn from epidemiological cancer registry data. Acta Otolaryngol 2011, 131:1205-1213.
25. Zhang B, Xu ZG, Tang PZ. Elective lateral neck dissection for laryngeal cancer in the clinically negative neck. J Surg Oncol 2006, 93:464-467.
26. Spector JG, Sessions DG, Chao KS, Hanson JM, Simpson JR, Perez CA. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery. Head Neck 1999, 21:116-123.
27. Haderlein M, Semrau S, Ott O, Speer S, Bohr C, Fietkau R. Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer. Strahlenther Onkol 2014, 190(2):192-198.
28. Studer G, Peponi E, Kloeck S, Dossenbach T, Huber G, Glanzmann C. Surviving hypopharynx-larynx carcinoma in the era of IMRT. Int J Radiat Oncol Biol Phys 2010, 77:1391-1396.
29. Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005, 63:410-421.
30. Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, Worden FP, Urba S, Lin A, Schipper MJ, Wolf GT. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004, 59:28-42.
31. Lee NY, O'Meara W, Chan K, Della-Bianca C, Mechalakos JG, Zhung J, Wolden SL, Narayana A, Kraus D, Shah JP, Pfister DG. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 2007, 69(2):459-68.
32. Nguyen NP, Chi A, Betz M, Almeida F, Vos P, Davis R, Slane B, Ceizyk M, Abraham D, Smith-Raymond L, Stevie M, Jang S, Gelumbauskas S, Vinh-Hung V. Feasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancer. PLoS One 2012, 7(8):e42729.
33. Penagaricano JA, Ratanatharathorn V, Papanikolaou N, Yan Y. Intensity-modulated radiation therapy reduces the dose to normal tissue in T2N0M0 squamous cell carcinoma of the glottic larynx. Med Dosim 2004, 29:254-257.
34. Feigenberg SJ, Lango M, Nicolaou N, Ridge JA. Intensity-modulated radiotherapy for early larynx cancer: is there a role?. Int J Radiat Oncol Biol Phys 2007, 68:2-3.
35. Groome PA, O'Sullivan B, Mackillop WJ, Irish J, Schulze K, Jackson LD, Bissett RJ, Dixon PF, Eapen LJ, Gulavita SP, Hammond JA, Hodson DI, Mackenzie RG, Schneider KM, Warde PR. Laryngeal cancer treatment and survival differences across regional cancer centres in Ontario. Canada Clin Oncol (R Coll Radiol) 2011, 23:19-28.